Free Trial

Tenaya Therapeutics (TNYA) Competitors

Tenaya Therapeutics logo
$0.61 0.00 (-0.29%)
Closing price 03:54 PM Eastern
Extended Trading
$0.61 0.00 (0.00%)
As of 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TNYA vs. CMPX, TECX, SLDB, HUMA, RZLT, ARCT, PRTA, CYRX, AQST, and SNDL

Should you be buying Tenaya Therapeutics stock or one of its competitors? The main competitors of Tenaya Therapeutics include Compass Therapeutics (CMPX), Tectonic Therapeutic (TECX), Solid Biosciences (SLDB), Humacyte (HUMA), Rezolute (RZLT), Arcturus Therapeutics (ARCT), Prothena (PRTA), CryoPort (CYRX), Aquestive Therapeutics (AQST), and SNDL (SNDL). These companies are all part of the "pharmaceutical products" industry.

Tenaya Therapeutics vs. Its Competitors

Tenaya Therapeutics (NASDAQ:TNYA) and Compass Therapeutics (NASDAQ:CMPX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation, risk and media sentiment.

Tenaya Therapeutics currently has a consensus price target of $6.25, suggesting a potential upside of 922.91%. Compass Therapeutics has a consensus price target of $12.67, suggesting a potential upside of 356.46%. Given Tenaya Therapeutics' higher possible upside, analysts clearly believe Tenaya Therapeutics is more favorable than Compass Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tenaya Therapeutics
0 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
3.00
Compass Therapeutics
0 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
3.10

Tenaya Therapeutics has a beta of 3, indicating that its share price is 200% more volatile than the S&P 500. Comparatively, Compass Therapeutics has a beta of 1.48, indicating that its share price is 48% more volatile than the S&P 500.

Compass Therapeutics has higher revenue and earnings than Tenaya Therapeutics. Compass Therapeutics is trading at a lower price-to-earnings ratio than Tenaya Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tenaya TherapeuticsN/AN/A-$111.13M-$1.16-0.53
Compass Therapeutics$850K451.44-$49.38M-$0.41-6.77

In the previous week, Compass Therapeutics had 1 more articles in the media than Tenaya Therapeutics. MarketBeat recorded 3 mentions for Compass Therapeutics and 2 mentions for Tenaya Therapeutics. Compass Therapeutics' average media sentiment score of 0.65 beat Tenaya Therapeutics' score of 0.00 indicating that Compass Therapeutics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tenaya Therapeutics
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Compass Therapeutics
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Compass Therapeutics' return on equity of -42.47% beat Tenaya Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Tenaya TherapeuticsN/A -92.20% -74.53%
Compass Therapeutics N/A -42.47%-38.31%

90.5% of Tenaya Therapeutics shares are held by institutional investors. Comparatively, 68.4% of Compass Therapeutics shares are held by institutional investors. 48.7% of Tenaya Therapeutics shares are held by insiders. Comparatively, 29.8% of Compass Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Compass Therapeutics beats Tenaya Therapeutics on 10 of the 15 factors compared between the two stocks.

Get Tenaya Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNYA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TNYA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TNYA vs. The Competition

MetricTenaya TherapeuticsMED IndustryMedical SectorNASDAQ Exchange
Market Cap$99.68M$2.91B$5.54B$8.95B
Dividend YieldN/A2.42%5.38%4.08%
P/E Ratio-0.5321.5627.4020.04
Price / SalesN/A281.10419.46118.60
Price / CashN/A41.9536.6357.47
Price / Book0.577.518.085.67
Net Income-$111.13M-$55.05M$3.16B$248.47M
7 Day Performance-11.64%3.16%2.12%2.90%
1 Month Performance24.69%5.92%4.43%5.75%
1 Year Performance-79.00%5.82%35.62%21.36%

Tenaya Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TNYA
Tenaya Therapeutics
3.0917 of 5 stars
$0.61
-0.3%
$6.25
+922.9%
-79.4%$99.68MN/A-0.53110
CMPX
Compass Therapeutics
3.213 of 5 stars
$2.55
+6.0%
$13.13
+415.7%
+197.7%$352.06M$850K-6.2120News Coverage
Analyst Upgrade
TECX
Tectonic Therapeutic
3.6212 of 5 stars
$18.81
-5.0%
$82.33
+337.6%
+33.1%$349.89MN/A-2.56120
SLDB
Solid Biosciences
3.4156 of 5 stars
$4.52
-5.7%
$14.90
+230.0%
-18.3%$349.18M$8.09M-1.51100Gap Up
HUMA
Humacyte
2.3542 of 5 stars
$2.21
-4.5%
$11.71
+430.8%
-54.8%$343.59M$1.57M-3.21150Gap Down
RZLT
Rezolute
3.01 of 5 stars
$4.03
-2.1%
$11.83
+194.0%
+15.4%$342.50MN/A-3.4840
ARCT
Arcturus Therapeutics
3.7723 of 5 stars
$12.49
+1.6%
$53.50
+328.3%
-36.6%$335.88M$152.31M-4.90180News Coverage
Analyst Forecast
PRTA
Prothena
2.7893 of 5 stars
$6.08
+6.3%
$31.50
+418.2%
-69.0%$328.58M$135.16M-2.93130High Trading Volume
CYRX
CryoPort
2.1252 of 5 stars
$6.57
+3.1%
$11.00
+67.5%
+20.4%$328.07M$228.38M-2.801,186Gap Down
AQST
Aquestive Therapeutics
1.5951 of 5 stars
$3.30
+1.4%
$10.14
+207.8%
+52.1%$325.60M$57.56M-5.56160News Coverage
SNDL
SNDL
3.3196 of 5 stars
$1.24
-1.2%
$3.63
+193.5%
-33.5%$324.53M$671.81M-4.262,516Positive News

Related Companies and Tools


This page (NASDAQ:TNYA) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners